Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Cancer Cell|December 29, 2023
Benchmarking mismatch repair testing for patients with cancer receiving immunotherapyElias Bou Farhat, Elio Adib, Melissa Daou, et al.
Gynecologic Oncology|September 10, 2002
A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapyMichael V Seiden, Kenneth D Swenerton, Ursula Matulonis, et al.
Gynecologic Oncology|December 17, 2003
Phase II trial of anastrozole in women with asymptomatic müllerian cancerMarcela G del Carmen, Arlan F Fuller, Ursula Matulonis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancerGiorgio Bogani, Robert L Coleman, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 15, 2023
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancerGiorgio Bogani, Robert L Coleman, Ignace Vergote, et al.
Cancer Genetics|March 21, 2012
Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survivalJoyce Liu, Mihaela C Cristea, Paul Frankel, et al.
Plos One|December 10, 2009
Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samplesCraig April, Brandy Klotzle, Thomas Royce, et al.
Pageof 8